Artwork

Content provided by Caroline Durham. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Caroline Durham or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ovarian Suppression Can Help Protect Ovarian Function and May Preserve Fertility in Younger Women Being Treated With Chemotherapy

9:09
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on April 01, 2022 06:22 (2y ago). Last successful fetch was on February 28, 2022 07:18 (2y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 193143374 series 1013829
Content provided by Caroline Durham. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Caroline Durham or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Preserving fertility after chemotherapy is an important issue for many, many younger women diagnosed with early-stage breast cancer. Dr. Matteo Lambertini, medical oncologist at the Institute Jules Bordet Brussels, presented research at the 2017 San Antonio Breast Cancer Symposium showing that ovarian suppression with a gonadotropin-releasing hormone analogue such as Lupron, Trelstar, or Zoladex, can safely protect ovarian function and may help preserve fertility in younger women being treated with chemotherapy for early-stage disease.Listen to the podcast to hear Dr. Lambertini explain: why earlier studies on this topic had mixed results the results of the study the side effects of gonadotropin-releasing hormone analogues the strategies he recommends to his younger patients diagnosed with early-stage breast cancer who want to have a child after chemotherapy Running time: 9:09
  continue reading

215 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on April 01, 2022 06:22 (2y ago). Last successful fetch was on February 28, 2022 07:18 (2y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 193143374 series 1013829
Content provided by Caroline Durham. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Caroline Durham or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Preserving fertility after chemotherapy is an important issue for many, many younger women diagnosed with early-stage breast cancer. Dr. Matteo Lambertini, medical oncologist at the Institute Jules Bordet Brussels, presented research at the 2017 San Antonio Breast Cancer Symposium showing that ovarian suppression with a gonadotropin-releasing hormone analogue such as Lupron, Trelstar, or Zoladex, can safely protect ovarian function and may help preserve fertility in younger women being treated with chemotherapy for early-stage disease.Listen to the podcast to hear Dr. Lambertini explain: why earlier studies on this topic had mixed results the results of the study the side effects of gonadotropin-releasing hormone analogues the strategies he recommends to his younger patients diagnosed with early-stage breast cancer who want to have a child after chemotherapy Running time: 9:09
  continue reading

215 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide